- Home
- TELO vs SATX Comparison
TELO vs SATX Comparison
Compare TELO & SATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELO
- SATX
- Stock Information
- Founded
- TELO 2021
- SATX 2012
- Country
- TELO United States
- SATX Israel
- Employees
- TELO N/A
- SATX N/A
- Industry
- TELO
- SATX Radio And Television Broadcasting And Communications Equipment
- Sector
- TELO
- SATX Technology
- Exchange
- TELO NYSE
- SATX Nasdaq
- Market Cap
- TELO 154.1M
- SATX 130.6M
- IPO Year
- TELO 2024
- SATX N/A
- Fundamental
- Price
- TELO $4.69
- SATX $1.42
- Analyst Decision
- TELO
- SATX Strong Buy
- Analyst Count
- TELO 0
- SATX 2
- Target Price
- TELO N/A
- SATX $2.25
- AVG Volume (30 Days)
- TELO 225.7K
- SATX 461.3K
- Earning Date
- TELO 02-12-2025
- SATX 02-14-2025
- Dividend Yield
- TELO N/A
- SATX N/A
- EPS Growth
- TELO N/A
- SATX N/A
- EPS
- TELO N/A
- SATX N/A
- Revenue
- TELO N/A
- SATX $10,351,000.00
- Revenue This Year
- TELO N/A
- SATX $80.62
- Revenue Next Year
- TELO N/A
- SATX N/A
- P/E Ratio
- TELO N/A
- SATX N/A
- Revenue Growth
- TELO N/A
- SATX N/A
- 52 Week Low
- TELO $3.11
- SATX $0.30
- 52 Week High
- TELO $20.72
- SATX $2.39
- Technical
- Relative Strength Index (RSI)
- TELO 50.83
- SATX 52.30
- Support Level
- TELO $4.05
- SATX $1.21
- Resistance Level
- TELO $5.17
- SATX $1.57
- Average True Range (ATR)
- TELO 0.45
- SATX 0.33
- MACD
- TELO 0.03
- SATX -0.04
- Stochastic Oscillator
- TELO 58.62
- SATX 23.02
About TELO TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company leading the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.
About SATX SatixFy Communications Ltd.
SatixFy Communications Ltd develops end-to-end next-generation satellite communications systems, including satellite payloads, user terminals and modems, based on powerful chipsets that it develops in house. Its products include modems that feature Software Defined Radio and Fully Electronically Steered Multi Beam Antennas that support the advanced communications standard DVB-S2X. Geographical presence in U.S, Canada, UK and Other countries. Majority of its company revenue comes from U.S and Canada.